Tifelle Reisinger

Associate Director, Medicinal Chemistry Discovery and Stakeholder Management

Dr Tifelle Reisinger is a medicinal chemist with over 15 years’ experience in small drug discovery experience in the pharmaceutical industry and contract research organisations (CRO) in France, UK and Australia.

Tifelle joined BioCurate in 2019 and as a Venture Partner, she managed the MRFF-BTB (Biomedical Translation Bridge) Program delivered by MTPConnect, in partnership with UniQuest and Medical Device Partnering Program.

With her medicinal chemistry expertise, Tifelle is responsible for identifying investment opportunities for development and commercialisation of therapeutics, as well as leading drug discovery campaigns for small molecule programs from hit identification through to candidate nomination.

Her previous roles have included medicinal chemist at CROs in the UK at Concept Life Sciences and Domainex and Head of Business Development Australia at Domainex. With a strong client-focus and business acumen, she generated and managed a portfolio of clients including biotech companies, venture capitals and leading academic research institutes across Australia.

Tifelle has a PhD from The University of Paris and the Institut de Chimie des Substances Naturelles (ICNS-CNRS), undertook postdoctoral studies at the University of Cambridge (UK) and is a Graduate of the Australian Institute of Company Directors.